Senior Management

Dr. STEVEN THERIAULT

BSc, MSc, PhD – Chief Executive Officer / Chief Science Officer

  • PhD Synthetic Biology with 20 years of research experience
  • Team member: created Canadian Ebola vaccine and diagnostic tools
  • Former Chief of the Applied Research Program at the Canadian Science Centre for Human and Animal
    Health
  • Numerous research publications
  • Implemented and developed Canadian biosafety and biosecurity guidelines and legislation
  • Developed Canadian emergency response
    contingency plans for transportation of infectious agents

JAMES KINLEY

CPA CA – Chief Financial Officer

  • Extensive experience in the biotech industry
  • Served as a CFO to several publicly listed healthcare companies over the past 15 years, including his current engagement as CFO to Algernon Health Inc (CSE: AGN).

BOARD OF DIRECTORS

THOMAS WELLNER

Chairman

  • highly experienced corporate executive with over three decades of global experience in biotechnology, pharmaceutical, and healthcare services companies
  • led several healthcare organizations, LifeLabs/CML Healthcare, and Therapure Biopharma. He recently retired as President and Chief Executive Officer of Revera Inc., a leading global owner, operator and developer in the senior living/healthcare sector.
  • currently serves on the board of Andlauer Health Group where he chairs the audit committee, and the board of the Ontario Teachers Pension Plan

Dr. STEVEN THERIAULT

Director

  • PhD Synthetic Biology with 20 years of research experience

  • Team member: created Canadian Ebola vaccine and diagnostic tools

  • Former Chief of the Applied Research Program at the Canadian Science Centre for Human and Animal
    Health

  • Numerous research publications

  • Implemented and developed Canadian biosafety and biosecurity guidelines and legislation

  • Developed Canadian emergency response
    contingency plans for transportation of infectious agents

ROBERT GABOR, KC

Director

  •  Lawyer with more than 35 years experience.
  • Practice focused on technology commercialization and corporate/commercial law, serving many early stage companies
  • Founder of leading Manitoba business accelerator

MICHAEL COCHRANE

Director

  • Investment banking veteran with more than 30 years of M&A and finance experience in both New York and Toronto
  • Coverage and management positions at Goldman, Sachs, Lehman Brothers, First Boston and CIBC
  •  

JOHN SNISARENKO

Director

  • 30+ years in pharmaceutical and biotech industries
  • Most recent position as Chief Commercial Officer for Oyster Point Pharma, where he led the launch planning, infrastructure building and commercial launch for Tyrvaya
  • Former VP & Franchise Head responsible for the commercial activities within Genentech’s Ophthalmology (Lucentis) and Rheumatology (Rituxan, Actemra) franchises for 10 years (all three medicines achieved over $1B in sales in the U.S. marketplace)

MICHAEL SORKIN

Director

  • 30+ years in commercial sales and marketing veteran of medical devices and services around the world
  • Launched and developed diverse and inclusive organizations for KMT Medical, Hollister,
    and Boston Scientific
  • Previously Chief Commercial Officer of Hollister, a major global player in the Ostomy and Continence Care markets

Countless
Applications

Bacteriophage therapy has unlimited uses and is effective in eradicating bacterial disease and infection in three key areas.

Food Safety

In food safety, our phages help prevent disease and the spread of disease, without introducing antibiotics into the food chain or the environment.

Animal Health

Cytophage is developing bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and growth enhancement in livestock, starting with poultry.

Human Health

In human health, phages can address a full range of bacterial illnesses and conditions, from treating acne and eczema, alleviating internal bacterial infections such as pneumonia, preventing wound infections and battling outbreaks such as cholera or diphtheria.

Phages can also be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern.

What is a
bacteriophage?

Bacteriophages are organisms that infect and kill bacterial cells. These natural killers of bacteria can overcome all of the cellular or organism-level defences.

WATCH THE VIDEO

What is a
bacteriophage?

Bacteriophages are organisms that infect and kill bacterial cells. These natural killers of bacteria can overcome all of the cellular or organism-level defences.

WATCH THE VIDEO

We can win the war against battlefield infection.
Cytophage was selected for the Defense Innovation Award 2019.

Winner of 2018 Nutreco Feed Tech Challenge
For our breakthrough innovation to help feed the world.

Contact Us

Learn more about our bacteriophage solutions.

Learn More
Get Cytophage Investor Alerts

Cytophage Technologies Ltd. © 2024